Difference between revisions of "Team:Michigan/Current"

Line 54: Line 54:
 
<p><br><strong>Immunofluorescence Antibody Assay (IFA) and Indirect Fluorescent Antibody Test (IFAT):</strong><br>These tests both rely on the use of fluorescently tagged antibodies binding to targets to report antigen presence. In immunofluorescence antibody assays, a specifically chosen primary fluorescently tagged antibody binds directly to an antigen of interest1 antibody tests, a specific primary antibody is bound to a target antigen while another fluorescently tagged secondary antibody binds to the primary antibody1 fluorescent signal would suggest the binding of antibodies to their specific antigens and a diagnosis for that disease could be made.<br><br>
 
<p><br><strong>Immunofluorescence Antibody Assay (IFA) and Indirect Fluorescent Antibody Test (IFAT):</strong><br>These tests both rely on the use of fluorescently tagged antibodies binding to targets to report antigen presence. In immunofluorescence antibody assays, a specifically chosen primary fluorescently tagged antibody binds directly to an antigen of interest1 antibody tests, a specific primary antibody is bound to a target antigen while another fluorescently tagged secondary antibody binds to the primary antibody1 fluorescent signal would suggest the binding of antibodies to their specific antigens and a diagnosis for that disease could be made.<br><br>
  
<strong>PCR:</strong><br>Currently, PCR is one of the most sensitive of the existing methods of detecting microbial pathogens<sup>2</sup> amplicons<sup>2</sup>to culture in vitro or require a long cultivation period<sup>2</sup> to using PCR. For example, PCR is susceptible to inhibitors and contamination<sup>2</sup> PCR is based on DNA amplification, meaning false­-positive or false-negative outcomes can easily occur<sup>2</sup> laboratory surfaces can also result in false­positive outcomes<sup>2</sup> disease detection must be performed in controlled environments and conditions. It involves DNA extraction from specimens, PCR amplification, and detection of This method of disease detection is particularly useful when pathogens are difficult However, there are also several downfalls Additionally,
+
<strong>PCR:</strong><br>Currently, PCR is one of the most sensitive of the existing methods of detecting microbial pathogens<sup>2</sup>. It involves DNA extraction from specimens, PCR amplification, and detection of amplicons<sup>2</sup>. This method of disease detection is particularly useful when pathogens are difficult to culture in vitro or require a long cultivation period<sup>2</sup>. However, there are also several downfalls to using PCR. For example, PCR is susceptible to inhibitors and contamination<sup>2</sup>. Additionally, PCR is based on DNA amplification, meaning false-positive or false-negative outcomes can easily occur<sup>2</sup>. Experimental conditions, such as contamination of reagents, pipettes, and laboratory surfaces can also result in false-positive outcomes<sup>2</sup>. Thus, PCR as a method of disease detection must be performed in controlled environments and conditions.<br><br>
  
. Experimental conditions, such as contamination of reagents, pipettes, and  
+
<strong>Enzyme-Linked Immunosorbent Assay (ELISA):</strong><br>Enzyme-linked immunosorbent assays are a common procedure used to detect specific antigens or antibodies not only to determine if they are present or not, but also the relative quantity present<sup>3</sup>. ELISAs are based on an enzyme-mediated color change, which indicates the presence of a specific antigen<sup>3</sup>. This method of disease detection is useful because in kits, it can be portable, easy to use, and inexpensive, meaning it could be ideal for large population screening or in low-resource settings<sup>3</sup>. However, ELISAs have some downfalls. For example, the enzyme-mediated color change continues to react over time, so the color strength could inaccurately display the amount of primary antibody present<sup>3</sup>. Further, nonspecific binding of antibody to the plate can lead to an atypically high positive result<sup>3</sup>.
  
. Thus, PCR as a method of method of
 
  
disease detection must be performed in controlled environments and conditions.</p>
+
 
 +
 
 +
 
 +
</p>
  
 
</html>
 
</html>

Revision as of 03:01, 14 September 2015

Current Disease Detection Methods:
Technological advancements in serological and molecular laboratory techniques have reduced the time and effort required to test for high profile diseases such as malaria, and tuberculosis, as well as neglected tropical diseases such as trypanosomiasis (chagas disease), dengue fever, and cysticercosis.

Parasitic Diseases

Viral Diseases


Immunofluorescence Antibody Assay (IFA) and Indirect Fluorescent Antibody Test (IFAT):
These tests both rely on the use of fluorescently tagged antibodies binding to targets to report antigen presence. In immunofluorescence antibody assays, a specifically chosen primary fluorescently tagged antibody binds directly to an antigen of interest1 antibody tests, a specific primary antibody is bound to a target antigen while another fluorescently tagged secondary antibody binds to the primary antibody1 fluorescent signal would suggest the binding of antibodies to their specific antigens and a diagnosis for that disease could be made.

PCR:
Currently, PCR is one of the most sensitive of the existing methods of detecting microbial pathogens2. It involves DNA extraction from specimens, PCR amplification, and detection of amplicons2. This method of disease detection is particularly useful when pathogens are difficult to culture in vitro or require a long cultivation period2. However, there are also several downfalls to using PCR. For example, PCR is susceptible to inhibitors and contamination2. Additionally, PCR is based on DNA amplification, meaning false-positive or false-negative outcomes can easily occur2. Experimental conditions, such as contamination of reagents, pipettes, and laboratory surfaces can also result in false-positive outcomes2. Thus, PCR as a method of disease detection must be performed in controlled environments and conditions.

Enzyme-Linked Immunosorbent Assay (ELISA):
Enzyme-linked immunosorbent assays are a common procedure used to detect specific antigens or antibodies not only to determine if they are present or not, but also the relative quantity present3. ELISAs are based on an enzyme-mediated color change, which indicates the presence of a specific antigen3. This method of disease detection is useful because in kits, it can be portable, easy to use, and inexpensive, meaning it could be ideal for large population screening or in low-resource settings3. However, ELISAs have some downfalls. For example, the enzyme-mediated color change continues to react over time, so the color strength could inaccurately display the amount of primary antibody present3. Further, nonspecific binding of antibody to the plate can lead to an atypically high positive result3.